IQVIA France

iqvia.com · Paris, France

IQVIA France is the French subsidiary of IQVIA, providing data, analytics, technology solutions, and contract research services to pharmaceutical, biotech, and healthcare organizations in France. It supports clients with real-world evidence, clinical development, commercial strategy, and market access using healthcare data and analytics platforms. The company generates revenue through consulting engagements, technology and data subscriptions, and outsourced research and commercialization services.

  • Clinical Trial & Research Software
  • IT Consulting & Implementation
  • Business Intelligence & Dashboards
Revenue
$600.0M
Employees
1,500
Founded
1999
Headquarters
Paris, France

What 166 Arbolus experts think of IQVIA France

NPS scores show a strong positive distribution, with most users rating 8 or above and a number of perfect 10s. Renewal intent is high among major influencers and decision-makers; some buyers express 'not sure' status, often related to pending adoption outcomes or evolving support and governance requirements. The majority of respondents are at the 'more than 1 year' implementation stage, indicating well-established usage. Key feedback themes highlight value in workflow optimization, strong analytics, and commercialization support, balanced against concerns of integration cost and governance complexity.Overall Customer Sentiment: Positive

Who reviewed IQVIA France

Total customers 166 157 current · 9 former
Reviews growth +121 in six months
Seniority of respondents
  • C-Suite 57% (95)
  • Director 29% (48)
  • Manager 14% (23)
Marketing Leader C-Suite NPS 9
Marketing Leader C-Suite NPS 9
Not specified C-Suite NPS 7 Undecided

Employer names and spend open in the full report, along with the other 163 customers.

Everything 166 customers told us about IQVIA France.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Open the full report

Sentiment

39 Net Promoter Score, from 166 scored reviews
  • Promoters 84
  • Passives 64
  • Detractors 18

Cumulative NPS by month

+0 over 6 months
  • May 8
  • Jun 8
  • Jul 8
  • Aug 8
  • Sep 8
  • Oct 8

Net Promoter Score across 3 reviews, accumulated up to each month. Category median 38 across 3 companies.

Praised

  • Operational Value and Targeting
  • Data Depth and Analytical Expertise
  • Prevention of Costly Amendments
  • Expanding Adoption to New Workflows

Criticised

  • Opaque Automation Risks
  • Lack of Real-Time Agility
  • Contracting Complexity
  • AI Opacity and Regulatory Compliance

What customers say

Operational Value and Targeting
“The solution improved our ability to analyze market performance and prescribing trends, resulting in more evidence-based portfolio planning and prioritization of high-value segments.”
Data Depth and Analytical Expertise
“I rely on IQVIA France for its extensive healthcare data, domain expertise, and strong analytics in pharma commercialization, which have significantly improved our commercial processes.”
Prevention of Costly Amendments
“Using advanced tools like Trials.ai allowed us to identify clinical protocol bottlenecks before finalization, saving money by avoiding protocol amendments after regulatory submission.”

Renewal intent

Plan to renew 48%
  • Will renew 19
  • Undecided 15
  • Not renewing 6

Plan to renew, by seniority

  • C-Suite 43% 23 answers
  • Director 58% 12 answers
  • Manager 40% 5 answers
  • 8.6/10 Average score from customers who will renew
  • 7.9/10 Average score from undecided customers
  • 6.2/10 Average score from customers not renewing

Top alternatives

Most weighed by IQVIA France customers

Report

For people who use IQVIA France

Do you use IQVIA France at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 166 customers of IQVIA France have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.